Arpeggio

Arpeggio

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://www.arpeggiobio.com

Last Round

Series A

Extension

Jan 30, 2024

Est. Valuation

$2.14M

Total Funding Raised

$24.38M

Momentum Score

50 /100

Company Overview

Arpeggio is a biotechnology company that offers a drug assessment technology platform combining proprietary biological assays and machine learning algorithms to provide rapid, high-resolution insights into cellular dynamics post-drug treatment, aiding medical scientists in identifying new drug targets and enhancing the success rate of new drugs in clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, ML Platforms, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

nascent RNA sequencingAI drug discoverydrug discovery platformtranscriptomicsmechanism of action analysisMoA analysisCRO servicesAI biotechundruggable targetshigh-throughput screeningtranscription factorspreclinical drug discoverychemotranscriptomicstherapeutic pipelinegene expression analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arpeggio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arpeggio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 30, 2024
Series ASep 7, 2022
SeedJan 15, 2020
AcceleratorAug 16, 2019

Key People

Founding team and executive leadership

Laura Norris

COO Co-founder

Founding Team

Joey Azofeifa

CEO Co-founder

Founding Team

Tim Read

Chief Technology Officer

Executive Team

Arpeggio Investors

Notable investors and investment history

InvestorRounds
Builders VCSeries A
Khosla VenturesSeries A, Seed
Tau VenturesSeries A
BoxOne VenturesSeries A
Y CombinatorSeed, Accelerator
FundersClubSeries A, Seed
ATEM CapitalSeries A

Arpeggio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arpeggio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arpeggio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range18
Year Founded2017
Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.